GET DAILY SIGNALSTrueBlue (TBI) Delivers +21% Revenue Growth in Q3 2026 with Profit Turnaround
Key Takeaways
- TrueBlue reported third quarter 2026 revenue of $520.7 million, up 21% year over year and above Wall Street consensus estimates.
- GAAP EPS came in at $0.33, while adjusted EPS was $0.28, both exceeding analyst expectations.
- Net income swung to $9.2 million from a net loss of $1.9 million in the prior-year quarter.
- Adjusted EBITDA nearly doubled to $20.7 million.
- All three reportable segments grew, led by a 34% jump in PeopleReady revenue driven by energy-related demand.
- Management guided to fourth-quarter revenue growth of 20% to 24% year over year.
Why These Results Matter
TrueBlue’s quarterly earnings provide a useful window into the U.S. contingent and on-demand labor market, which tends to reflect changes in industrial activity, energy spending, and employer confidence. The company has been shifting its focus toward higher-growth skilled and healthcare areas, and this report serves as a clear test of whether that repositioning is producing lasting revenue momentum. After four straight quarters of revenue growth, investors were looking to see if TrueBlue could keep expanding while also lifting profitability and operating efficiency. A solid outcome would support management’s strategy in these end markets, whereas any shortfall might prompt questions about how broad and sustainable the labor-market recovery really is.
A Closer Look at the Numbers
TrueBlue reported third quarter 2026 revenue of $520.7 million, an increase of 21% from $431.3 million in the same period last year and comfortably ahead of consensus estimates that clustered near the mid-$450 million range. Net income reached $9.2 million, or $0.33 per diluted share, compared with a net loss of $1.9 million a year earlier. Adjusted EPS of $0.28 also topped analyst forecasts of roughly $0.17 to $0.19. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted EBITDA nearly doubled to $20.7 million from $10.6 million in the prior-year quarter, reflecting better operating leverage. Gross margin was 20.5%, down from 22.7% a year ago, mainly due to revenue mix as lower-margin PeopleReady energy work expanded rapidly. Segment results were broad-based: PeopleReady revenue rose 34% to $338.0 million, PeopleManagement grew 2% to $135.4 million, and PeopleSolutions edged up 1% to $47.4 million.
How the Market Is Responding
Sentiment heading into the report had been cautiously optimistic, with a rebound in the shares over the trailing twelve months reflecting growing confidence in TrueBlue’s turnaround. The third-quarter print reinforced that narrative: revenue, EPS, and adjusted profitability all exceeded expectations, and management pointed to a fifth consecutive quarter of top-line growth. The key debate for investors is now less about whether demand is recovering and more about the quality and durability of that growth, particularly given the outsized contribution from energy work, which management noted can fluctuate from quarter to quarter.
What to Watch Going Forward
TrueBlue guided to fourth-quarter revenue growth of 20% to 24% year over year, with management expecting improved trends across all three segments and steady sequential gross margin. That outlook suggests the company believes momentum will carry into year-end even as some of the larger energy project volumes normalize.
Investors should monitor a few key areas. First, watch the sustainability of PeopleReady’s energy vertical, which doubled revenue in the quarter but is inherently lumpy; a pullback in that business would pressure growth comparisons. Second, track the On-Demand business, which grew for a second straight quarter, as a signal that core demand is firming beyond skilled niches. Third, keep an eye on working capital and cash flow, since stronger-than-expected revenue drove a roughly $35 million increase in working capital during the quarter.
Finally, gross margin trends and cost discipline will matter. Management reduced SG&A expense by 3% while growing revenue 21%, a sign of meaningful operating leverage. Sustaining that balance, while converting growth into free cash flow as working capital normalizes, will be central to how investors evaluate the next phase of TrueBlue’s recovery. From what I see, TBI’s ability to balance these factors will determine whether the recent momentum holds.
Using AI Tools to Refine My Analysis
In my own research process, I frequently rely on Tickeron’s Trending AI Robots to scan for additional market opportunities and compare sector trends alongside individual earnings reports. The tool helps surface ideas that align with the same themes I’m already tracking, such as labor-market recovery and energy-related demand, without replacing the detailed fundamental work. It has become a practical way to broaden perspective while staying focused on the core investment thesis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TBI in upward trend: 10-day moving average broke above 50-day moving average on November 03, 2026
The 10-day moving average for TBI crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TBI's RSI Oscillator exited the oversold zone, 26 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on TBI as a result. In 61 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for TBI just turned positive on October 23, 2026. Looking at past instances where TBI's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
TBI moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where TBI advanced for three days, in 199 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
TBI broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TBI entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.176) is normal, around the industry mean (4.783). P/E Ratio (-5.234) is within average values for comparable stocks, (1.574). Projected Growth (PEG Ratio) (0.782) is also within normal values, averaging (1.448). Dividend Yield (0.000) settles around the average of (1.469) among similar stocks. P/S Ratio (0.161) is also within normal values, averaging (0.884).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. TBI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TBI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of temporary blue-collar staffing services
Industry OtherConsumerServices
Advertisement